GEN News Highlights

Life Technologies Offers Next-Gen Platform to University of Cambridge’s Sequencing Hub

is providing three SOLiD™ 3 Plus Systems to the European research and clinical communities through the Eastern Sequence and Informatics Hub at Addenbrooke’s Hospital in Cambridge. The technology will be leveraged in diseases such as cancer, diabetes, and neurological disorders to advance targeted medical resequencing and whole-transcriptome analysis research studies.

The hub was established with funding from the Medical Research Council and from the University of Cambridge’s Clinical School and NIHR Biomedical Research Centre to accelerate the use of genetic information to help identify new therapies, diagnostics, and preventive strategies.

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.

If you have any questions about your subscription, click
hereto email us or call at (914) 740-2189.

You may also be interested in subscribing to the GEN magazine, an indispensable
resource for everyone involved in the business of translating discoveries at the
bench into solutions that fight disease and improve health, agriculture, and the
environment. Subscribe
today to see why over 60,000 biotech professionals read GEN to
keep current in the areas of genomics, proteomics, drug discovery, biomarker discovery,
bioprocessing, molecular diagnostics, collaborations, biotech business trends, and
more.